For the quarter ending 2025-09-30, CGON made $61,882K in revenue. -$43,808K in net income. Net profit margin of -70.79%.
| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Total operating expenses | - | 42,256 | 29,156 | 28,338 |
| Total revenues | 1,666 | 52 | 365 | 43 |
| Cost of sales | 1,577 | - | - | - |
| Research and development | 27,884 | 27,467 | 20,827 | 19,622 |
| General and administrative | 23,334 | 14,789 | 8,329 | 8,716 |
| Total operating costs and expenses | 52,795 | - | - | - |
| Loss from operations | -51,129 | -42,204 | -28,790 | -28,295 |
| Interest income, net | 7,421 | 7,747 | 6,244 | 7,892 |
| Other (expense) income, net | -100 | 5 | 2 | -2 |
| Total other income, net | 7,321 | 7,752 | 6,246 | 7,890 |
| Net loss and comprehensive loss | -43,808 | -34,452 | -22,545 | -20,405 |
| Net loss attributable to common stockholders | - | - | -22,545 | -20,405 |
| Earnings per share, basic, total | -0.57 | -0.45 | -0.37 | -0.3 |
| Earnings per share, diluted, total | -0.57 | -0.45 | -0.37 | -0.3 |
| Weighted average number of shares outstanding, basic, total | 76,729,726 | 76,187,621 | -1,549,006.333 | 67,143,744 |
| Weighted average number of shares outstanding, diluted, total | 76,729,726 | 76,187,621 | -1,549,006.333 | 67,143,744 |
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)